Mary Rinella

25PUBLICATIONS
95CO-AUTHORS
Ngā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)Palliative careRegenerative medicine (incl. stem cells)Sport and exercise nutritionMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 30, 2026
The economic burden of MASH: comparison of healthcare resource utilization and costs in patients with probable MASH, without MASH, and with diagnosed MASH.

|Jun 19, 2026
The Transitional Liver Clinic: Study protocol for a stepped-wedge cluster randomized trial.

|Mar 19, 2026
Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management.

Mary E Rinella, Silvia Sookoian

|Jan 22, 2026
Response to "Aspirin for Primary Prevention in Metabolic Dysfunction-Associated Steatotic Liver Disease".

Tsubasa Tsutsumi, Michael R Charlton, Takumi Kawaguchi

|Jan 07, 2026
MASLD as a complication of obesity must include liver risk stratification.

Mary E Rinella, Arun J Sanyal, Rohit Loomba

|Oct 23, 2025
Practical Considerations for the Use of Semaglutide in MASH.

Matthew A Odenwald, Mary E Rinella

Pageof 5

Frequent Collaborators

7 joint publications

Rohit Loomba

5 joint publications

Jeffrey V Lazarus

4 joint publications

Aleksander Krag

4 joint publications

Brent Neuschwander-Tetri